Browsing by Author Martiniello-Wilks, R

0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Showing results 1 to 20 of 34  next >
Issue DateTitleAuthor(s)
Jan-2007Cell And Gene Therapy In AustraliaMartiniello-Wilks, R; Rasko, J
1-Aug-2015CELLULAR AND GENETIC MEDICINES ADVANCING THE TREATMENT OF METASTATIC PROSTATE CANCERSuurbach, JH; Habib, R; Brennan, S; Larsen, SR; Simpson, A; Martiniello-Wilks, R
Jan-2006Combination of cytosine deaminase with uracil phosphoribosyl transferase leads to local and distant bystander effects against RM1 prostate cancer in miceKhatri, A; Zhang, B; Doherty, E; Chapman, JC; Ow, K; Pwint, H; Martiniello-Wilks, R; Russell, P
Jan-2010Concise Review: Nanoparticles And Cellular Carriers-Allies In Cancer Imaging And Cellular Gene Therapy?Tang, C; Russell, P; Martiniello-Wilks, R; Rasko, J; Khatri, A
9-Mar-2017CRISPR-targeted genome editing of mesenchymal stem cell-derived therapies for type 1 diabetes: a path to clinical success?Gerace, D; Martiniello-Wilks, R; Nassif, NT; Lal, S; Steptoe, R; Simpson, AM
Jan-2002Derivation of MPR And TRAMP models of prostate cancer and prostate cancer metastasis for evaluation of therapeutic strategiesVoeks, D; Martiniello-Wilks, R; Russell, P
29-Jan-2015Diabetes reversal via gene transfer: building on successes in animal modelsGerace, D; Martiniello-Wilks, R; Simpson, AM
Jan-2011Evaluation Of Cell Cycle Arrest In Estrogen Responsive MCF-7 Breast Cancer Cells: Pitfalls Of The MTS AssayMcGowan, EM; Alling, N; Jackson, E; Yagoub, D; Haass, NK; Allen, J; Martiniello-Wilks, R
1-Aug-2015EXOSOMAL MICRORNA: POTENTIAL URINARY AND PLASMA BASED BIOMARKERS FOR THE DIAGNOSIS AND PROGNOSIS OF PROSTATE CANCERBrennan, S; Tran, N; Clayton, A; Webber, J; Cozzi, P; Martiniello-Wilks, R
1-Jan-2014First use of Re: View: A tool to combine assessment tasks, marking criteria and graduate attributes for biochemistry studentsNield, BS; Guzowski, R; Nassif, N; Simpson, AM; Martiniello-Wilks, R
1-Nov-2015Gene therapy for diabetes: reversal of diabetes in the humanised FRG mouse modelSimpson, A; Ren, B; O'Brien, BA; Alexander, IE; Nassif, NT; Tan, Y; Martiniello-Wilks, R
1-Nov-2015GENE THERAPY FOR DIABETES: REVERSAL OF DIABETES IN THE HUMANISED FRG MOUSE MODEL.Simpson, A; Ren, B; O'Brien, BA; Alexander, IE; Nassif, NT; Tan, Y; Martiniello-Wilks, R
Jan-2002Gene therapy for prostate cancer delivered by ovine adenovirus and mediated by purine nucleoside phosphorylase and fludarabine in mouse modelsVoeks, D; Martiniello-Wilks, R; Madden, V; Smith, K; Bennetts, E; Both, G; Russell, P
Jan-2004Gene-directed enzyme prodrug therapy for prostate cancer in a mouse model that imitates the development of human diseaseMartiniello-Wilks, R; Dane, A; Voeks, D; Jeyakumar, G; Mortensen, E; Shaw, J; Wang, X; Both, G; Russell, P
Jan-2004Immunohistochemical characterisation of the monoclonal antibody BLCA-38 for the detection of prostate cancerRussell, P; Ow, K; Tam, P; Juarez, J; Kingsley, E; Qu, C; Li, Y; Cozzi, P; Martiniello-Wilks, R
Jan-2008Improved granulocyte colony-stimulating factor mobilization of hemopoietic progenitors using cytokine combinations in primatesLarsen, S; Chng, K; Battah, F; Martiniello-Wilks, R; Rasko, J
Jan-1998In vivo gene therapy for prostate cancer: Preclinical evaluation of two different enzyme-directed prodrug therapy systems delivered by identical adenovirus vectorsMartiniello-Wilks, R; Garcia-aragon, J; Daja, M; Russell, P; Both, G; Molloy, P; Lockett, L; Russell, P
Jan-1996Ly-6C(+) natural T (NT) cells mediate immune surveillance against NK-sensitive and NK-resistant transplantable tumours in certain strains of miceMartiniello-Wilks, R; Burton, R; Smart, Y
Jan-1994Monoclonal-Antibody 2B6-F2 Identifies A Subset Of Murine Natural-Killer-Cells With Receptors For YAC-1 And WEHI-164 TargetsMartiniello-Wilks, R; Smart, Y; Burton, R
Jan-1997Natural cell-mediated cytotoxicity (NCMC) against NK-sensitive tumours in vitro by murine spleen Ly-6C(+) natural T cellsMartiniello-Wilks, R; Burton, R; Smart, Y